<DOC>
	<DOCNO>NCT03039335</DOCNO>
	<brief_summary>The objective study prospectively ass whether interval first symptom initial diagnosis experience patient newly diagnose alpha-1 antitrypsin deficiency ( AATD ) ass whether diagnostic interval associate worsen clinical status time initial diagnosis .</brief_summary>
	<brief_title>The Impact Delayed Diagnosis Alpha-1 Antitrypsin Deficiency</brief_title>
	<detailed_description>The study protocol propose assess participant ' clinical status base result spirometry test perform patient 's managing physician routine part clinical care individual AATD within +/- 6 month initial diagnosis , subject ' St. George 's Respiratory Questionnaire ( SGRQ ) time initial diagnosis , COPD Assessment Test ( CAT ) result time initial diagnosis AATD ( hereafter call `` time zero '' T0 define day patient 's test show AATD blood work submit test Biocerna LLC patient ' manage physician part routine clinical management ) . After offer verbal consent , subject complete survey assess various clinical domain , include demographic feature , AATD ascertain , initial symptom ascribable AATD , number healthcare provider ( specific type provider ) see initial diagnosis , clinical status T0 within define , relatively narrow temporal window ( +/- 6 month ) T0 . As prior study , diagnostic interval define duration self-reported initial symptom AATD ( usually dyspnea &gt; 80 % cases3 ) initial confirm diagnosis AATD ( T0 ) .</detailed_description>
	<mesh_term>Alpha 1-Antitrypsin Deficiency</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>18 year age older Positive AATD Test Result Previous Positive AATD Test Result Negative Test Result AATD</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>